Differences in International Recommendations for Piperacillin Dosing: A Japanese Perspective

Area of Science:

• Pharmacology
• Infectious Diseases
• Antimicrobial Stewardship

Background:

• Divergent international and Japanese dosing recommendations for piperacillin highlight a global tension between maximizing antibiotic efficacy and ensuring patient safety.
• Piperacillin dosing strategies differ significantly, with international guidelines (e.g., Sanford Guide) favoring higher doses for critically ill patients in intensive care units (ICUs) based on pharmacokinetic/pharmacodynamic (PK/PD) principles, while Japanese labeling suggests lower doses for broader populations to minimize adverse events.

Purpose of the Study:

• To analyze the contrasting philosophies behind international and Japanese piperacillin dosing recommendations.
• To underscore the clinical implications of inappropriately applying these divergent dosing strategies across different patient populations and settings.
• To emphasize the importance of antimicrobial stewardship in optimizing piperacillin use.

Main Methods:

• Comparative analysis of international (Sanford Guide) and Japanese package insert recommendations for piperacillin dosing.
• Review of pharmacokinetic/pharmacodynamic principles guiding high-dose regimens in critically ill patients.
• Assessment of potential adverse events and therapeutic outcomes associated with different dosing strategies.

Main Results:

• High-dose piperacillin regimens (13.5-27 g/day) aim to achieve PK/PD targets in ICUs but may increase risks (allergy, GI disturbance, bone marrow suppression, renal injury, resistance) in general wards.
• Low-dose regimens (2-4 g/day, max 16 g/day) prioritize safety in general populations but risk suboptimal exposure and treatment failure for severe infections (e.g., *Pseudomonas aeruginosa*) in ICUs.
• Indiscriminate application of either strategy can lead to significant clinical consequences, including therapeutic failure or increased adverse events.

Conclusions:

• Awareness of differing piperacillin dosing philosophies and their intended applications is essential for effective antimicrobial stewardship.
• Clinicians must individualize piperacillin dosing based on the clinical context, reserving aggressive regimens for critically ill or high-risk patients.
• Safety-oriented dosing should be maintained in routine ward practice to optimize patient outcomes and minimize antibiotic-associated risks and ecological burden.